Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence

Carla M Nappi, Sean P.A. Drummond, Joshua M.H. Hall

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Emerging evidence supports the notion of disrupted sleep as a core component of Posttraumatic Stress Disorder (PTSD). Effective treatments for nighttime PTSD symptoms are critical because sleep disruption may be mechanistically linked to development and maintenance of PTSD and is associated with significant distress, functional impairment, and poor health. This review aimed to describe the state of science with respect to the impact of the latest behavioral and pharmacological interventions on posttraumatic nightmares and insomnia. Published studies that examined evidence for therapeutic effects upon sleep were included. Some behavioral and pharmacological interventions show promise, especially for nightmares, but there is a need for controlled trials that include valid sleep measures and are designed to identify treatment mechanisms. Our ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. 

Original languageEnglish
Pages (from-to)576-585
Number of pages10
JournalNeuropharmacology
Volume62
Issue number2
DOIs
Publication statusPublished - Feb 2012
Externally publishedYes

Keywords

  • Insomnia
  • Nightmares
  • Posttraumatic stress disorder
  • Sleep

Cite this

@article{0dc848ac59b143bb8d32f507b8023870,
title = "Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence",
abstract = "Emerging evidence supports the notion of disrupted sleep as a core component of Posttraumatic Stress Disorder (PTSD). Effective treatments for nighttime PTSD symptoms are critical because sleep disruption may be mechanistically linked to development and maintenance of PTSD and is associated with significant distress, functional impairment, and poor health. This review aimed to describe the state of science with respect to the impact of the latest behavioral and pharmacological interventions on posttraumatic nightmares and insomnia. Published studies that examined evidence for therapeutic effects upon sleep were included. Some behavioral and pharmacological interventions show promise, especially for nightmares, but there is a need for controlled trials that include valid sleep measures and are designed to identify treatment mechanisms. Our ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. ",
keywords = "Insomnia, Nightmares, Posttraumatic stress disorder, Sleep",
author = "Nappi, {Carla M} and Drummond, {Sean P.A.} and Hall, {Joshua M.H.}",
year = "2012",
month = "2",
doi = "10.1016/j.neuropharm.2011.02.029",
language = "English",
volume = "62",
pages = "576--585",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier",
number = "2",

}

Treating nightmares and insomnia in posttraumatic stress disorder : A review of current evidence. / Nappi, Carla M; Drummond, Sean P.A.; Hall, Joshua M.H.

In: Neuropharmacology, Vol. 62, No. 2, 02.2012, p. 576-585.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Treating nightmares and insomnia in posttraumatic stress disorder

T2 - A review of current evidence

AU - Nappi, Carla M

AU - Drummond, Sean P.A.

AU - Hall, Joshua M.H.

PY - 2012/2

Y1 - 2012/2

N2 - Emerging evidence supports the notion of disrupted sleep as a core component of Posttraumatic Stress Disorder (PTSD). Effective treatments for nighttime PTSD symptoms are critical because sleep disruption may be mechanistically linked to development and maintenance of PTSD and is associated with significant distress, functional impairment, and poor health. This review aimed to describe the state of science with respect to the impact of the latest behavioral and pharmacological interventions on posttraumatic nightmares and insomnia. Published studies that examined evidence for therapeutic effects upon sleep were included. Some behavioral and pharmacological interventions show promise, especially for nightmares, but there is a need for controlled trials that include valid sleep measures and are designed to identify treatment mechanisms. Our ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. 

AB - Emerging evidence supports the notion of disrupted sleep as a core component of Posttraumatic Stress Disorder (PTSD). Effective treatments for nighttime PTSD symptoms are critical because sleep disruption may be mechanistically linked to development and maintenance of PTSD and is associated with significant distress, functional impairment, and poor health. This review aimed to describe the state of science with respect to the impact of the latest behavioral and pharmacological interventions on posttraumatic nightmares and insomnia. Published studies that examined evidence for therapeutic effects upon sleep were included. Some behavioral and pharmacological interventions show promise, especially for nightmares, but there is a need for controlled trials that include valid sleep measures and are designed to identify treatment mechanisms. Our ability to treat PTSD-related sleep disturbances may be improved by moving away from considering sleep symptoms in isolation and instead conducting integrative studies that examine sequential or combined behavioral and/or pharmacological treatments targeting both the daytime and nighttime aspects of PTSD. 

KW - Insomnia

KW - Nightmares

KW - Posttraumatic stress disorder

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84855948581&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2011.02.029

DO - 10.1016/j.neuropharm.2011.02.029

M3 - Review Article

VL - 62

SP - 576

EP - 585

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 2

ER -